FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Beam To Complete Clinical Hold Studies This Year

[ Price : $8.95]

Beam Therapeutics says it will complete studies requested by FDA as part of a clinical hold on a Beam-201 cancer treatment IND and...

Ubrelvy Regulatory Review Period Determined

[ Price : $8.95]

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Allergans Ubrelvy (ubrogepa...

Regulatory Review Period for TherOx Downstream System

[ Price : $8.95]

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for TherOxs PMA for the TherOx ...

CGMP Violations at Green Wave Analytical

[ Price : $8.95]

FDA warns San Diego, CA-based Green Wave Analytical about CGMP and other violations in its work as a contract testing laboratory f...

Priority Review for Sanofis Efanesoctocog Alfa

[ Price : $8.95]

FDA grants priority review for a Sanofi BLA for efanesoctocog alfa to treat hemophilia A.

Priority Review Voucher Used on Lillys Mounjaro

[ Price : $8.95]

Federal Register notice: FDA announces that Eli Lilly used a priority review voucher for the approval of its NDA for Mounjaro (tir...

EUA for Novavax Covid-19 Vaccine

[ Price : $8.95]

Federal Register notice: FDA announces an Emergency Use Authorization issued 7/13 to Novavax, Inc. for its Novavax Covid19 Vaccine...

Device Cybersecurity Firm Hires Former FDA Reviewer

[ Price : $8.95]

Medical device cybersecurity consulting firm MedCrypt hires former CDRH Diabetes Diagnostics Device Branch lead reviewer Naomi Sch...

FDA Clears BrainsWay Device for Depression

[ Price : $8.95]

FDA clears a BrainsWay 510(k) for its Deep TMS H7 Coil for use in treating adults suffering from major depressive disorder and dep...

Florida Sues FDA Over Drug Importation Plan

[ Price : $8.95]

The state of Florida files a lawsuit against FDA for failing to timely respond to a state-sought Freedom of Information Act reques...